NLSP - 2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC HOTH NLSP PSTV IMMX GNPX NRBO)
2021 was a year to be easily forgotten for biotech stocks. The S&P 500 climbed 26.9%. However, SPDR S&P Biotech exchange-traded fund dropped 20.5%. Looks like 2022 will be “THE” year for biotech sector. In a recent note from Piper Sandler analyst Christopher Raymond and his colleagues, Raymond said that he recommended “selective buying” of […]
For further details see:
2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)